Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Long-Term Deferred Tax (2016 - 2024)

Historic Long-Term Deferred Tax for Bruker (BRKRP) over the last 16 years, with Q4 2024 value amounting to $286.2 million.

  • Bruker's Long-Term Deferred Tax fell 370.12% to $286.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $286.2 million, marking a year-over-year decrease of 370.12%. This contributed to the annual value of $286.2 million for FY2024, which is 370.12% down from last year.
  • Bruker's Long-Term Deferred Tax amounted to $286.2 million in Q4 2024, which was down 370.12% from $340.9 million recorded in Q3 2024.
  • Bruker's 5-year Long-Term Deferred Tax high stood at $340.9 million for Q3 2024, and its period low was $72.0 million during Q4 2020.
  • Its 5-year average for Long-Term Deferred Tax is $218.3 million, with a median of $283.2 million in 2024.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first plummeted by 1476.14% in 2022, then surged by 28697.92% in 2023.
  • Bruker's Long-Term Deferred Tax (Quarter) stood at $72.0 million in 2020, then grew by 25.14% to $90.1 million in 2021, then dropped by 14.76% to $76.8 million in 2022, then surged by 286.98% to $297.2 million in 2023, then decreased by 3.7% to $286.2 million in 2024.
  • Its Long-Term Deferred Tax stands at $286.2 million for Q4 2024, versus $340.9 million for Q3 2024 and $303.2 million for Q2 2024.